Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CYAD

Celyad

$21.35

(0.00%)

, ADAP

Adaptimmune

$3.83

-0.06 (-1.54%)

08:06
03/20/19
03/20
08:06
03/20/19
08:06
Conference/Events
William Blair to hold a conference »

9th Annual Cancer…

CYAD

Celyad

$21.35

(0.00%)

ADAP

Adaptimmune

$3.83

-0.06 (-1.54%)

ADRO

Aduro Biotech

$3.92

-0.1 (-2.49%)

ALLO

Allogene Therapeutics

$26.25

-0.53 (-1.98%)

ATRA

Atara Biotherapeutics

$39.18

0.02 (0.05%)

AUTL

Autolus Therapeutics

$25.05

0.05 (0.20%)

BLCM

Bellicum Pharmaceuticals

$3.62

0.06 (1.69%)

CALA

Calithera Biosciences

$6.50

-0.08 (-1.22%)

DVAX

Dynavax

$8.00

0.24 (3.09%)

FATE

Fate Therapeutics

$18.00

-0.35 (-1.91%)

HARP

Harpoon Therapeutics

$12.10

0.1 (0.83%)

INFI

Infinity Pharmaceuticals

$1.80

(0.00%)

MRK

Merck

$81.93

0.59 (0.73%)

MRUS

Merus

$12.85

-0.15 (-1.15%)

NKTR

Nektar

$34.40

-0.5 (-1.43%)

PFE

Pfizer

$42.32

0.51 (1.22%)

PIRS

Pieris Pharmaceuticals

$3.22

-0.11 (-3.30%)

RCUS

Arcus Biosciences

$11.64

-0.12 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Mar

  • 20

    Mar

  • 20

    Mar

  • 04

    Apr

  • 08

    Apr

  • 09

    Apr

  • 09

    Apr

  • 11

    Apr

  • 30

    Apr

  • 30

    Apr

  • 18

    May

  • 23

    May

  • 24

    May

  • 17

    Jun

Over a week ago
HARP

Harpoon Therapeutics

$11.84

0.83 (7.54%)

16:08
03/14/19
03/14
16:08
03/14/19
16:08
Earnings
Harpoon Therapeutics reports Q4 EPS ($8.15), two estimates (73c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Mar

  • 20

    Mar

HARP

Harpoon Therapeutics

$16.99

0.83 (5.14%)

07:59
03/05/19
03/05
07:59
03/05/19
07:59
Initiation
Harpoon Therapeutics initiated at Canaccord »

Harpoon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HARP

Harpoon Therapeutics

$16.99

0.83 (5.14%)

07:52
03/05/19
03/05
07:52
03/05/19
07:52
Initiation
Harpoon Therapeutics initiated at Canaccord »

Harpoon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HARP

Harpoon Therapeutics

$16.99

0.83 (5.14%)

07:23
03/05/19
03/05
07:23
03/05/19
07:23
Initiation
Harpoon Therapeutics initiated  »

Wedbush bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HARP

Harpoon Therapeutics

$16.99

0.83 (5.14%)

06:44
03/05/19
03/05
06:44
03/05/19
06:44
Initiation
Harpoon Therapeutics initiated at Wedbush »

Harpoon Threapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a month ago
HARP

Harpoon Therapeutics

$0.00

(0.00%)

11:26
02/08/19
02/08
11:26
02/08/19
11:26
Syndicate
Breaking Syndicate news story on Harpoon Therapeutics »

Harpoon Threapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

HARP

Harpoon Therapeutics

$0.00

(0.00%)

11:23
02/08/19
02/08
11:23
02/08/19
11:23
Syndicate
Harpoon Threapeutics indicated to open at $14.00, IPO priced at $14.00 »

Harpoon Threapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

HARP

Harpoon Therapeutics

$0.00

(0.00%)

19:42
02/07/19
02/07
19:42
02/07/19
19:42
Syndicate
Harpoon Threapeutics 5.4M share IPO priced at $14.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.